Cargando…

Association between vitamin D deficiency and vasovagal syncope: A systematic review and meta‐analysis

Vasovagal syncope (VVS) is the most prevalent type of syncope and its management includes pharmacologic and non‐pharmacologic interventions. Recently, studies have investigated vitamin D levels in VVS patients. In this systematic review and meta‐analysis, we aim to review these studies to find possi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalaji, Amirmohammad, Behnoush, Amir Hossein, Tajdini, Masih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352974/
https://www.ncbi.nlm.nih.gov/pubmed/37226313
http://dx.doi.org/10.1002/clc.24035
Descripción
Sumario:Vasovagal syncope (VVS) is the most prevalent type of syncope and its management includes pharmacologic and non‐pharmacologic interventions. Recently, studies have investigated vitamin D levels in VVS patients. In this systematic review and meta‐analysis, we aim to review these studies to find possible associations between vitamin D deficiency and vitamin D levels with VVS. International databases including Scopus, Web of Science, PubMed, and Embase were searched with keywords related to “vasovagal syncope” and “vitamin D.” Studies were screened and the data were extracted from them. Random‐effect meta‐analysis was conducted to calculate the standardized mean difference (SMD) and 95% confidence interval (CI) for vitamin D levels in comparison to VVS patients and controls. Also, VVS occurrence was measured and the odds ratio (OR) and 95% CI were calculated for comparison of vitamin D deficient cases and nondeficient individuals. Six studies were included with 954 cases investigated. Meta‐analysis showed that patients with VVS had significantly lower vitamin D serum levels in comparison to non‐VVS cases (SMD −1.05, 95% CI −1.54 to −0.57, p‐value < .01). Moreover, VVS occurrence was higher in vitamin D‐deficient individuals (OR 5.43, 95% CI 2.40 to 12.27, p‐value < .01). Our findings which show lower vitamin D levels in VVS patients can have clinical implications in order for clinicians to pay attention to this when approaching VVS. Further randomized controlled trials are certainly warranted to assess the role of vitamin D supplementation in individuals with VVS.